Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease-Reference-Cited by-同舟云学术

Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease

Published:2024-07 Issue: Volume: Page:
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Kwon Yun^ORCID,Gottmann Pascal^ORCID,Wang Surui,Tissink Joel^ORCID,Motzler Karsten^ORCID,Sekar Revathi^ORCID,Albrecht Wiebke^ORCID,Cadenas Cristina^ORCID,Hengstler Jan G.,Schürmann Annette,Zeigerer Anja^ORCID

Funder

Bundesministerium für Bildung und Forschung

Horizon 2020

DFG

BMBF Berlin

European Commission

European Foundation for the Study of Diabetes

Publisher

Elsevier BV

Reference45 articles.

1. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: what we need in the future;Araujo;Liver Int,2018

2. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis;Harrison;N Engl J Med,2024

3. Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation;Teumer;Nat Commun,2018

4. Evolving role for pharmacotherapy in NAFLD/NASH;Attia;Clin Transl Sci,2021

5. 3-D PSF fitting for fluorescence microscopy: implementation and localization application;Kirshner;J Microsc,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics;Nutrients;2024-09-11